Cargando…

Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations

Detalles Bibliográficos
Autores principales:	Lionetto, Luana, Martelletti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759361/ https://www.ncbi.nlm.nih.gov/pubmed/28132352 http://dx.doi.org/10.1186/1129-2377-16-S1-A36

Ejemplares similares

Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015)

Invasive neurostimulation
por: Mercieri, Marco, et al.
Publicado: (2015)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome
por: Van den Steen, Philippe E, et al.
Publicado: (2010)

Developing sub-acute, non-acute and special groups in the universal grouper
por: Aljunid, Syed Mohamed
Publicado: (2012)

Developing sub-acute and non-acute Casemix classification: the Thailand experience
por: Pannarunothai, Supasit
Publicado: (2012)

Is there a role for cytokine-immune based therapy in HIV disease therapy?
por: Poli, Guido
Publicado: (2010)

S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Treatment of septic arthritis and acute osteomyelitis
por: Peltola, Heikki
Publicado: (2014)

Statistical issues in the analysis of non-pharmacological therapy trials with clustering by care-provider or therapy group
por: Roberts, Chris
Publicado: (2011)

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response
por: Dalgleish, A, et al.
Publicado: (2014)

The acute response of tendon to loading: implications for rehabilitation
por: Wearing, Scott C, et al.
Publicado: (2011)

Universal access to anti-HIV therapy
por: Souteyrand, Yves
Publicado: (2012)

Hybrids and mini-cutting: a powerful combination that has revolutionized the Eucalyptus clonal forestry
por: Assis, Teotônio Francisco
Publicado: (2011)

Gene therapy to cure HIV? Prospects and realities
por: Hütter, Gero
Publicado: (2012)

Molecular approach to food allergy diagnosis and therapy
por: van Ree, Ronald
Publicado: (2011)

Diagnosis of food allergy and practical management of anaphylaxis: acute management
por: Roberts, Graham
Publicado: (2011)

PReS13-SPK-1129: Biologic therapies in SLE
por: Isenberg, DA
Publicado: (2013)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

PReS13-SPK-1572: The therapy management of pain amplification syndrome
por: Maillard, S
Publicado: (2013)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Biological substrates of migraine
por: Calabresi, Paolo
Publicado: (2015)

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing
por: Reuther, S, et al.
Publicado: (2014)

Lighting a candle in the dark: advances in the genetics and (gene) therapy of retinal dystrophies
por: den Hollander, Anneke I
Publicado: (2012)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
por: Mcinnes, I
Publicado: (2013)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
por: Schmoll, H, et al.
Publicado: (2014)

Genomics and epigenomics
por: Garagnani, Paolo, et al.
Publicado: (2015)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8kbulp8r62omftgv81ek9l2330